pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    IRX-4204
    Parkinson's Disease Io Therapeutics Inc
  • Preclinical
    IS-101
    InvisiMask
    Coronavirus Disease 2019 (COVID-19) InvisiShield Technologies Ltd
  • Phase 1
    ISB-2001
    Refractory Multiple Myeloma$ABBV AbbVie Inc.
  • Phase 1
← prev
page 110 of 271
next →
Pain89
Neurology1
ISM-3412
Solid Tumor
InSilico Medicine
  • Phase 1
    ISM-6331
    Malignant Mesothelioma InSilico Medicine
  • Preclinical
    ISM-9274
    Solid Tumor InSilico Medicine
  • Phase 2
    ISN-001
    Diabetic Foot Ulcers Anterogen Co Ltd
  • ISOLYTE S PH 7.4
    ISOLYTE S PH 7.4 (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE)
    no indication B BRAUN
  • Phase 2
    ISP-001
    Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Immusoft Corp
  • Preclinical
    ISP-002
    Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Immusoft Corp
  • ISTURISA
    ISTURISA (OSILODROSTAT PHOSPHATE)
    no indication Recordati SpA
  • Preclinical
    ISX9-CPC
    Cardiomyopathy IPS Heart Inc
  • Phase 1
    ITI-1001
    Glioblastoma Multiforme (GBM) Immunomic Therapeutics Inc
  • Phase 1
    ITI-3000
    Merkel Cell Carcinoma Immunomic Therapeutics Inc
  • ITOVEBI
    ITOVEBI (INAVOLISIB)
    no indication Genentech Inc
  • Preclinical
    ITR-2401
    Androgenic Alopecia Solipharma LLC
  • IVABRADINE
    IVABRADINE
    no indication ANNORA PHARMA
  • Phase 2
    IVB-001
    Metabolic Dysfunction-Associated Steatotic Liver Disease… Invictus Therapeutics Ltd
  • Phase 1
    IVB-003
    Pancreatic Cancer Invictus Therapeutics Ltd
  • Phase 2
    IVMED-80
    Keratoconus$GKOS GLAUKOS Corp
  • Phase 1
    IVMED-85
    Myopia iVeena Delivery Systems Inc
  • IVRA
    IVRA (MELPHALAN HCL)
    no indication APOTEX
  • Phase 2
    IVS-3001
    Epithelial Ovarian Cancer Invectys SA
  • Preclinical
    IVT-8086
    Osteosarcoma Innova Therapeutics Inc
  • Phase 2
    IVW-1001
    Keratoconjunctivitis Sicca (Dry Eye) iView Therapeutics Inc
  • Preclinical
    IVW-1802
    Myopia iView Therapeutics Inc
  • Preclinical
    IXTV-100
    Substance (Drug) Abuse InterveXion Therapeutics LLC
  • IZERVAY
    IZERVAY (AVACINCAPTAD PEGOL SODIUM)
    no indication Astellas Pharma Inc
  • Marketed
    Iheezo
    Iheezo (chloroprocaine [INN])
    Local Anesthetic Effect$HROW HARROW, INC.
  • Phase 3
    IkT-001
    Pulmonary Arterial Hypertension$IKT Inhibikase Therapeutics, Inc.